ImmunityBio, Inc. — Director's Dealing 2017

Jun 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2017-06-20

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-20	Common Stock	S	20000	$7.43	Disposed	409725	Direct
2017-06-20	Common Stock	S	20000	$8.13	Disposed	389725	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	521720	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.